Publications found:
264
Sort by:
The 2027-2032 World Outlook for Antihypertensive Drugs
US$ 1,195.00
This study covers the world outlook for antihypertensive drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
Global Heparin Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Heparin market size is expected to reach $ 2508 million by 2032, rising at a market growth of 7.6% CAGR during the forecast period (2026-2032). In 2024, global Heparin production reached ap...
January 2026
116 pages
Anti-hypertensive Drugs Market Size, Share & Trends Analysis Report By Product (ACE Inhibitors (ACEIs), Angiotensin II Receptor Blockers (ARBs)), By Type, By Route Of Administration (Oral, Transdermal), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global anti-hypertensive drugs market size was estimated at USD 25.88 billion in 2025 and is projected to reach USD 35.32 billion by 2033, growing at a CAGR of 3.96% from 2026 to 2033. The market...
December 2025
150 pages
Anticoagulants Market Size, Share & Trends Analysis Report By Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), By Route of Administration, By Application (Deep Vein Thrombosis (DVT)), Pulmonary Embolism), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global anticoagulants market size was estimated at USD 37.35 billion in 2025 and is projected to reach USD 55.72 billion by 2033, growing at a CAGR of 5.26% from 2026 to 2033. The rising prevalen...
December 2025
100 pages
Beta blockers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Non-selective Agents, Selective Agents), By Indication (Angina Pectoris, Heart Failure, High Blood Pressure, Others), By Drugs (Betaxolol, Acebutolol, Esmolol, Others), By Distribution Channel (Hospital Pharmacy; Retail Pharmacy; Online Pharmacy), By Application (Cardiac Diseases, Hypertension, Glaucoma, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Beta blockers Market, valued at USD 9.94 Billion in 2024, is projected to experience a CAGR of 5.95% to reach USD 14.06 Billion by 2030. Beta blockers represent a class of pharmaceutical ag...
December 2025
185 pages
Cardiovascular Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Surgical Procedures, Interventional Procedures, Non-invasive Procedures), By Indication (Ischemic Heart Disease), By Care Setting, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global cardiovascular treatment market size was estimated at USD 241.18 billion in 2024 and is projected to reach USD 383.11 billion by 2033, growing at a CAGR of 5.1% from 2025 to 2033. This mark...
November 2025
150 pages
Anticoagulants Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes), By Route Of Administration (Oral Anticoagulant, Injectable Anticoagulant), By Distribution Channel, By Application, By End User
US$ 3,950.00
The Anticoagulants Market is valued at USD 49.6 billion in 2025 and is projected to grow at a CAGR of 10.3% to reach USD 119.9 billion by 2034.The Anticoagulants Market focuses on the development and...
October 2025
160 pages
Beta Blockers Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Non-selective Agents, Selective Agents), By Indication (Angina Pectoris, Heart Failure, High Blood Pressure, Other Indications), By Drugs, By Distribution Channel, By Application
US$ 3,950.00
The Beta Blockers Market is valued at USD 8.9 billion in 2025 and is projected to grow at a CAGR of 7.1% to reach USD 16.5 billion by 2034.The beta blockers market remains a cornerstone of cardiovascu...
October 2025
160 pages
Congenital Heart Disease (Chd) Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types), By Diagnosis, By Treatment, By Age Group, By Application,
US$ 3,950.00
The Congenital Heart Disease (Chd) Market is valued at USD 5.8 billion in 2025 and is projected to grow at a CAGR of 9.7% to reach USD 13.3 billion by 2034.The congenital heart disease (CHD) market is...
October 2025
160 pages
End Stage Renal Disease (Esrd) Drug Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Other Products), By Indication (End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkaliemia), By Distribution Channel, By End User
US$ 3,950.00
The End Stage Renal Disease (Esrd) Drug Market is valued at USD 133.5 billion in 2025 and is projected to grow at a CAGR of 15.8% to reach USD 498.3 billion by 2034. Market Overview: End Stage Renal D...
October 2025
160 pages
Angina Pectoris Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drugs (Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs), By Indication (Stable Angina, Unstable Angina, Prinzmetal’s Angina), By Route of Administration, By End User
US$ 3,950.00
The Angina Pectoris Drugs Market is valued at USD 10.8 billion in 2025 and is projected to grow at a CAGR of 5.1% to reach USD 16.8 billion by 2034. Angina Pectoris Drugs Market The Angina Pectoris Dr...
October 2025
160 pages
Angiotensin Receptor Blockers (Arbs) Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan), By Application (Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications), By End User
US$ 3,950.00
The Angiotensin Receptor Blockers (Arbs) Market is valued at USD 10.4 billion in 2025 and is projected to grow at a CAGR of 3.9% to reach USD 14.7 billion by 2034. Angiotensin Receptor Blockers (ARBs)...
October 2025
160 pages
Anti-Hypertensive Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Therapeutics (Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators), By Disease Source (Primary Hypertension, Secondary Hypertension), By End Users
US$ 3,950.00
The Anti-Hypertensive Drugs Market is valued at USD 32.7 billion in 2025 and is projected to grow at a CAGR of 2.8% to reach USD 41.9 billion by 2034.The Anti-Hypertensive Drugs Market focuses on the...
October 2025
160 pages
Atherosclerosis Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Anti-Platelet Medications, Fibric Acid And Omega-3 Fatty Acid Derivatives, Angiotensin-Covering Enzyme (ACE) Inhibitors, Diuretics, Cholesterol Lowering Medication, Beta Blockers, Calcium Channel Blockers, Other Drug Classes), By Route Of Administration (Oral, Injectable), By Distribution Channel
US$ 3,950.00
The Atherosclerosis Drugs Market is valued at USD 45 billion in 2025 and is projected to grow at a CAGR of 4% to reach USD 63.8 billion by 2034. Atherosclerosis Drugs Market The atherosclerosis drugs...
October 2025
160 pages
Deep Vein Thrombosis Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Anticoagulants, Inferior Vena Cava Filters, Other Drug Class), By Treatment (Surgery, Drugs, Other Treatments), By Mode Of Administration, By Distribution Channel, By End User
US$ 3,950.00
The Deep Vein Thrombosis Market is valued at USD 1.4 billion in 2025 and is projected to grow at a CAGR of 5% to reach USD 2.2 billion by 2034.The Deep Vein Thrombosis (DVT) Market focuses on the diag...
October 2025
160 pages
Epinephrine Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Prefilled Syringe, Auto-injector, Ampoules and Vials), By Application (Anaphylaxis, Cardiac Arrest, Superficial Bleeding, Respiratory Disorders, Other Applications), By Distribution Channel
US$ 3,950.00
The Epinephrine Market is valued at USD 3.7 billion in 2025 and is projected to grow at a CAGR of 11.7% to reach USD 10 billion by 2034. Epinephrine Market Overview The global epinephrine market is ex...
October 2025
160 pages
Focal Segmental Glomerulosclerosis Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Losmapimod, SHP-627, Sparsentan, TM-5484, Other Types), By Treatment (Corticosteroids, Immunosuppressive Drugs, Angiotensin Converting Enzymes (ACE) Inhibitors, A.R. Blockers, Diuretics, Other Treatments), By Route of Administration, By End User
US$ 3,950.00
The Focal Segmental Glomerulosclerosis Drugs Market is valued at USD 13.8 billion in 2025 and is projected to grow at a CAGR of 9.5% to reach USD 31.2 billion by 2034.The Focal Segmental Glomeruloscle...
October 2025
160 pages
Hypertrophic Cardiomyopathy (Hcm) Therapeutics Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Antiarrhythmic Agents, Anticoagulants, Beta Adrenergic Blocking Agents, Calcium Channel Blockers, Other Drug Types), By Device Type (Defibrillators, Pacemakers, Other Device Types), By End User
US$ 3,950.00
The Hypertrophic Cardiomyopathy (Hcm) Therapeutics Market is valued at USD 1.7 billion in 2025 and is projected to grow at a CAGR of 2.6% to reach USD 2.1 billion by 2034.The Hypertrophic Cardiomyopat...
October 2025
160 pages
Hypolipidemics Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Cholic Acid Regulator, HMG-CoA Reductase Inhibitors, Adenylate Cyclase Inhibitors, Nicotinic Acid Drugs, Other Types), By Drug Type (Statins, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, PCSK9 Inhibitors, Other Drug Types), By Application
US$ 3,950.00
The Hypolipidemics Market is valued at USD 26.9 billion in 2025 and is projected to grow at a CAGR of 4.4% to reach USD 39.7 billion by 2034.The Hypolipidemics Market, focused on lipid-lowering drugs,...
October 2025
160 pages
Inotropic Agents Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Positive Inotropic Drugs, Negative Inotropic Drugs, Other Types), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Indication, By Distribution Channel, By End User
US$ 3,950.00
The Inotropic Agents Market is valued at USD 3.4 billion in 2025 and is projected to grow at a CAGR of 12.7% to reach USD 9.9 billion by 2034.The inotropic agents market comprises pharmaceutical drugs...
October 2025
160 pages
Ischemic Heart Disease (Ihd) Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Anti-Dyslipidemic Drugs, Calcium Channel Blockers, Beta-Blockers, Angiotensin-converting enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Vasodilators, Antithrombotic Agents), By Disease Class (Angina Pectoris, Myocardial Infarction), By End User
US$ 3,950.00
The Ischemic Heart Disease (Ihd) Drugs Market is valued at USD 7.9 billion in 2025 and is projected to grow at a CAGR of 6.3% to reach USD 13.7 billion by 2034.The Ischemic Heart Disease (IHD) Drugs M...
October 2025
160 pages
Late Stage Chronic Kidney Disease Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders), By Indication Type (Late Stage Chronic Kidney Disease Induced Hyperparathyroidism, Late Stage Chronic Kidney Disease Induced Hyperphosphatemia, Late Stage Chronic Kidney Disease Induced Hyperkalemia), By Distribution Channel
US$ 3,950.00
The Late Stage Chronic Kidney Disease Drugs Market is valued at USD 9.8 billion in 2025 and is projected to grow at a CAGR of 11.1% to reach USD 25.3 billion by 2034.The late stage chronic kidney dise...
October 2025
160 pages
Lipid Regulators Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Lipid Regulators, Narcotic Analgesics, Angiotensin Converting Enzyme (ACE) Inhibitors, Respiratory Agents, Diuretics, Calcium Antagonists, Hormonal Contraceptives, Other Types), By Indication (Hypercholesterolemia, Hypertriglyceridemia, Coronary Artery Disease, Other Indications), By Administration, By Application
US$ 3,950.00
The Lipid Regulators Market is valued at USD 9.7 billion in 2025 and is projected to grow at a CAGR of 5.9% to reach USD 16.3 billion by 2034.The lipid regulators market involves pharmaceutical produc...
October 2025
160 pages
Paroxysmal Nocturnal Hemoglobinuria (Pnh) Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment Type (Medications, Bone Marrow Transplantation, Blood Transfusion, Immunosuppressive Therapy, Other Treatment Types), By Diagnosis Type (Flow Cytometry, High-Resolution Mass Spectrometry, Other Diagnosis Types), By End Use
US$ 3,950.00
The Paroxysmal Nocturnal Hemoglobinuria (Pnh) Market is valued at USD 5.8 billion in 2025 and is projected to grow at a CAGR of 10.6% to reach USD 14.4 billion by 2034.The Paroxysmal Nocturnal Hemoglo...
October 2025
160 pages
Pericarditis Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Acute Pericarditis, Chronic Pericarditis, Recurrent Pericarditis ), By Diagnosis And Treatment (Electrocardiogram (ECG), Echocardiogram, Computerized Tomography (CT), X-Ray, Medication, Surgical Treatment), By Application
US$ 3,950.00
The Pericarditis Market is valued at USD 3 billion in 2025 and is projected to grow at a CAGR of 7.4% to reach USD 5.7 billion by 2034. Pericarditis Market Overview The pericarditis market is witnessi...
October 2025
160 pages
Rare Kidney Diseases Market Outlook 2025-2034: Market Share, and Growth Analysis By Target Indication (IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications), By Type of Molecule ( Small Molecules, Biologics), By Route of administration
US$ 3,950.00
The Rare Kidney Diseases Market is valued at USD 3.8 billion in 2025 and is projected to grow at a CAGR of 12.7% to reach USD 11.1 billion by 2034. Market Overview The rare kidney diseases market is a...
October 2025
160 pages
Thrombophilia Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type), By Drugs (Heparin, Warfarin, Other Drugs), By Route Of Administration, By End-Users
US$ 3,950.00
The Thrombophilia Market is valued at USD 14.9 billion in 2025 and is projected to grow at a CAGR of 7.4% to reach USD 28.2 billion by 2034.The Thrombophilia Market encompasses diagnostics, treatment,...
October 2025
160 pages
Global Nifedipine Market Growth 2025-2031
US$ 3,660.00
... the base year being 2017) and the growth prospects of global Nifedipine market for 2018-2023. Nifedipine is a drug that belongs to the ... and forecast to 2023. To understand the structure of Nifedipine market by identifying its various subsegments. Focuses on the key global Nifedipine manufacturers, to define ...
October 2025
113 pages
Global Clopidogrel Bisulfate Market Growth 2025-2031
US$ 3,660.00
... the global market share (sales and revenue) of key companies in Clopidogrel Bisulfate business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Clopidogrel Bisulfate market ...
October 2025
106 pages
Global Peptide and Anticoagulant Drugs Market Growth 2025-2031
US$ 3,660.00
... RESEARCH OBJECTIVES To study and analyze the global Peptide and Anticoagulant Drugs consumption (value & volume) by key regions ... the structure of Peptide and Anticoagulant Drugs market by identifying its various subsegments. Focuses on the key global Peptide and Anticoagulant Drugs manufacturers, to define ...
October 2025
129 pages
